| P2093 | author name string | Nikos Maniadakis | |
| | Panagiotis Prezerakos | |
| | Fotini Gialama | |
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
| | Generalized cost-effectiveness analysis for national-level priority-setting in the health sector | Q24807372 |
| | The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis | Q27013747 |
| | Medical economics and the assessment of value in cardiovascular medicine: Part I. | Q33183977 |
| | Medical economics and the assessment of value in cardiovascular medicine: Part II. | Q33183995 |
| | Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). | Q33248754 |
| | Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis | Q33612554 |
| | Economic outcomes of implantable cardioverter-defibrillators | Q33855108 |
| | Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II). | Q34018568 |
| | Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy. | Q34088903 |
| | Cost-effectiveness of implantable cardioverter-defibrillators. | Q34457211 |
| | Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs | Q35201110 |
| | Implantable defibrillators and sudden cardiac death | Q35796629 |
| | Challenges in systematic reviews of economic analyses | Q36169168 |
| | Challenges in systematic reviews of therapeutic devices and procedures | Q36169185 |
| | Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. | Q36247555 |
| | A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. | Q37274482 |
| | Systematic reviews of economic evaluations: utility or futility? | Q37451168 |
| | Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries | Q39602715 |
| | Advances in the prevention and treatment of cardiovascular disease | Q40253320 |
| | Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure | Q40508209 |
| | An analysis of the cost effectiveness of the implantable defibrillator | Q41207571 |
| | Frequency of sudden cardiac death and profiles of risk | Q41589898 |
| | Interpretation of cost-effectiveness analyses | Q42337459 |
| | Therapeutic drug monitoring: antiarrhythmic drugs | Q42780616 |
| | Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). | Q43540414 |
| | Cost-effectiveness of the implantable cardioverter defibrillator? | Q43643211 |
| | Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study | Q43753469 |
| | Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector. | Q43783695 |
| | Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction | Q43802128 |
| | Quality of life in the Canadian Implantable Defibrillator Study (CIDS). | Q44102810 |
| | Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator | Q44135200 |
| | Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention | Q44443112 |
| | Cost-effectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment | Q46708261 |
| | Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy | Q46925780 |
| | Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context | Q47360980 |
| | Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly | Q47734265 |
| | Impact of the implantable cardioverter-defibrillator on rehospitalizations. | Q50617487 |
| | Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. | Q50967484 |
| | Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. | Q51079366 |
| | The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. | Q51187876 |
| | Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. | Q51324493 |
| | Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. | Q51498611 |
| | Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. | Q53628646 |
| | Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. | Q53639140 |
| | Sudden Cardiac Death | Q56593283 |
| | Cost-effectiveness of implantable cardioverter-defibrillators | Q57007573 |
| | Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada | Q57589526 |
| | Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population | Q57759167 |
| | Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death | Q58394577 |
| P433 | issue | 1 | |
| P921 | main subject | defibrillator | Q1450682 |
| | systematic review | Q1504425 |
| P304 | page(s) | 41-49 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Applied Health Economics and Health Policy | Q15764758 |
| P1476 | title | The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations | |
| P478 | volume | 12 | |